(-)-demecolcine increases expression ISO SLC2A5 (Homo sapiens) 6480464 Demecolcine results in increased expression of SLC2A5 mRNA CTD PMID:23649840 1,2-dichloroethane decreases expression ISO Slc2a5 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of SLC2A5 mRNA CTD PMID:28189721 and PMID:28960355 1,2-dimethylhydrazine decreases expression ISO Slc2a5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SLC2A5 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO Slc2a5 (Mus musculus) 6480464 Estradiol results in decreased expression of SLC2A5 mRNA CTD PMID:19484750 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLC2A5 mRNA CTD PMID:32145629 2,3,4,7,8-Pentachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC2A5 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC2A5 mRNA CTD PMID:20959002 and PMID:21724226 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 3',5'-cyclic AMP affects expression ISO SLC2A5 (Homo sapiens) 6480464 Cyclic AMP affects the expression of SLC2A5 mRNA CTD PMID:8554516 3',5'-cyclic AMP multiple interactions EXP 6480464 [[Colforsin results in increased abundance of Cyclic AMP] which results in increased expression of SLC2A5 protein] which results in increased uptake of Fructose and [Colforsin results in increased abundance of Cyclic AMP] which results in increased expression of SLC2A5 protein CTD PMID:8037665 3',5'-cyclic AMP multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 [Fructose results in increased abundance of Cyclic AMP] which results in increased stability of SLC2A5 mRNA CTD PMID:12820898 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 3,3',5-triiodo-L-thyronine multiple interactions EXP 6480464 [Triiodothyronine co-treated with Fructose] results in increased expression of SLC2A5 mRNA CTD PMID:17485832 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SLC2A5 mRNA CTD PMID:28522335 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of SLC2A5 protein CTD PMID:34915118 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SLC2A5 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of SLC2A5 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol decreases expression ISO SLC2A5 (Homo sapiens) 6480464 bisphenol S results in decreased expression of SLC2A5 mRNA CTD PMID:27685785 and PMID:30616060 4,4'-sulfonyldiphenol decreases expression ISO Slc2a5 (Mus musculus) 6480464 bisphenol S results in decreased expression of SLC2A5 mRNA CTD PMID:33297965 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC2A5 mRNA CTD PMID:31881176 acrylamide increases expression ISO Slc2a5 (Mus musculus) 6480464 Acrylamide results in increased expression of SLC2A5 mRNA CTD PMID:30807115 actinomycin D multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [Fructose promotes the reaction [SLC2A5 protein results in increased uptake of Fructose]] and Dactinomycin inhibits the reaction [Fructose results in increased expression of SLC2A5 mRNA] CTD PMID:11123204 aflatoxin B1 increases expression ISO SLC2A5 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of SLC2A5 mRNA CTD PMID:21641981 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of SLC2A5 protein CTD PMID:8048533 aldehydo-D-glucose increases expression ISO Slc2a5 (Mus musculus) 6480464 Glucose results in increased expression of SLC2A5 mRNA CTD PMID:12937289 aldehydo-D-glucose increases transport ISO SLC2A5 (Homo sapiens) 6480464 SLC2A5 protein results in increased transport of Glucose CTD PMID:17710649 aldehydo-D-glucose increases expression ISO SLC2A5 (Homo sapiens) 6480464 Glucose results in increased expression of SLC2A5 mRNA and Glucose results in increased expression of SLC2A5 protein CTD PMID:12820898 and PMID:8554516 aldehydo-D-glucose multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 Colforsin promotes the reaction [Glucose results in increased expression of SLC2A5 mRNA] and Glucose promotes the reaction [PAIP2 protein binds to SLC2A5 3' UTR] CTD PMID:12820898 all-trans-retinoic acid increases expression ISO SLC2A5 (Homo sapiens) 6480464 Tretinoin results in increased expression of SLC2A5 mRNA and Tretinoin results in increased expression of SLC2A5 protein CTD PMID:15498508 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC2A5 mRNA CTD PMID:16483693 amphotericin B decreases expression ISO SLC2A5 (Homo sapiens) 6480464 Amphotericin B analog results in decreased expression of SLC2A5 mRNA CTD PMID:28534445 antirheumatic drug decreases expression ISO SLC2A5 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of SLC2A5 mRNA CTD PMID:24449571 arsane increases transport ISO SLC2A5 (Homo sapiens) 6480464 SLC2A5 protein results in increased transport of Arsenic CTD PMID:22214486 arsenic atom increases transport ISO SLC2A5 (Homo sapiens) 6480464 SLC2A5 protein results in increased transport of Arsenic CTD PMID:22214486 arsenous acid increases expression ISO SLC2A5 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of SLC2A5 mRNA CTD PMID:22214486 benzo[a]pyrene multiple interactions ISO Slc2a5 (Mus musculus) 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to SLC2A5 promoter] CTD PMID:19654925 benzo[a]pyrene affects methylation ISO SLC2A5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC2A5 3' UTR more ... CTD PMID:27901495 benzo[a]pyrene decreases expression ISO SLC2A5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC2A5 mRNA CTD PMID:20064835 beta-naphthoflavone decreases expression ISO SLC2A5 (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased expression of SLC2A5 mRNA CTD PMID:32858204 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC2A5 mRNA CTD PMID:25181051 bisphenol A increases expression ISO SLC2A5 (Homo sapiens) 6480464 bisphenol A results in increased expression of SLC2A5 protein CTD PMID:34186270 bisphenol A affects methylation ISO SLC2A5 (Homo sapiens) 6480464 bisphenol A affects the methylation of SLC2A5 gene CTD PMID:31601247 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC2A5 mRNA CTD PMID:32145629 bisphenol A multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC2A5 gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SLC2A5 mRNA CTD PMID:28628672 and PMID:31601247 bisphenol F increases expression ISO SLC2A5 (Homo sapiens) 6480464 bisphenol F results in increased expression of SLC2A5 protein CTD PMID:34186270 bucladesine multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 Bucladesine results in increased expression of and results in increased stability of SLC2A5 mRNA and N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Bucladesine results in increased expression of and results in increased stability of SLC2A5 mRNA] CTD PMID:12820898 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of SLC2A5 mRNA CTD PMID:19167457 cadmium atom decreases expression ISO Slc2a5 (Mus musculus) 6480464 Cadmium results in decreased expression of SLC2A5 mRNA CTD PMID:24067728 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of SLC2A5 mRNA CTD PMID:25993096 calcitriol decreases expression ISO SLC2A5 (Homo sapiens) 6480464 Calcitriol results in decreased expression of SLC2A5 mRNA CTD PMID:16002434 carbon nanotube affects expression ISO Slc2a5 (Mus musculus) 6480464 Nanotubes and Carbon analog affects the expression of SLC2A5 mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO Slc2a5 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of SLC2A5 mRNA CTD PMID:25620056 chromium(6+) affects expression ISO Slc2a5 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of SLC2A5 mRNA CTD PMID:28472532 cisplatin increases expression ISO SLC2A5 (Homo sapiens) 6480464 Cisplatin results in increased expression of SLC2A5 mRNA CTD PMID:27594783 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of SLC2A5 mRNA CTD PMID:19224547 clofibrate affects expression ISO Slc2a5 (Mus musculus) 6480464 Clofibrate affects the expression of SLC2A5 mRNA CTD PMID:23811191 colforsin daropate hydrochloride multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 Colforsin promotes the reaction [Fructose results in increased expression of SLC2A5 mRNA] and Colforsin promotes the reaction [Glucose results in increased expression of SLC2A5 mRNA] CTD PMID:12820898 colforsin daropate hydrochloride multiple interactions EXP 6480464 [[Colforsin results in increased abundance of Cyclic AMP] which results in increased expression of SLC2A5 protein] which results in increased uptake of Fructose more ... CTD PMID:8037665 colforsin daropate hydrochloride increases expression ISO SLC2A5 (Homo sapiens) 6480464 Colforsin results in increased expression of SLC2A5 mRNA CTD PMID:12820898 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of SLC2A5 mRNA CTD PMID:27523638 curcumin decreases expression ISO Slc2a5 (Mus musculus) 6480464 Curcumin results in decreased expression of SLC2A5 mRNA CTD PMID:21397623 cycloheximide multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [Fructose promotes the reaction [SLC2A5 protein results in increased uptake of Fructose]] CTD PMID:11123204 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of SLC2A5 mRNA CTD PMID:19224547 D-glucose multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 Colforsin promotes the reaction [Glucose results in increased expression of SLC2A5 mRNA] and Glucose promotes the reaction [PAIP2 protein binds to SLC2A5 3' UTR] CTD PMID:12820898 D-glucose increases expression ISO SLC2A5 (Homo sapiens) 6480464 Glucose results in increased expression of SLC2A5 mRNA and Glucose results in increased expression of SLC2A5 protein CTD PMID:12820898 and PMID:8554516 D-glucose increases expression EXP 6480464 Glucose results in increased expression of SLC2A5 protein CTD PMID:8048533 D-glucose increases expression ISO Slc2a5 (Mus musculus) 6480464 Glucose results in increased expression of SLC2A5 mRNA CTD PMID:12937289 D-glucose increases transport ISO SLC2A5 (Homo sapiens) 6480464 SLC2A5 protein results in increased transport of Glucose CTD PMID:17710649 dexamethasone affects expression EXP 6480464 Dexamethasone affects the expression of SLC2A5 mRNA CTD PMID:15102944 dexamethasone multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SLC2A5 mRNA CTD PMID:28628672 dexamethasone multiple interactions EXP 6480464 Dexamethasone promotes the reaction [Fructose results in increased activity of SLC2A5 protein] more ... CTD PMID:18556366 and PMID:20032058 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of SLC2A5 mRNA CTD PMID:20032058 diarsenic trioxide increases expression ISO SLC2A5 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of SLC2A5 mRNA CTD PMID:22214486 diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of SLC2A5 mRNA CTD PMID:21161181 dimethylarsinic acid multiple interactions ISO Slc2a5 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC2A5 mRNA CTD PMID:34876320 epoxiconazole decreases expression ISO Slc2a5 (Mus musculus) 6480464 epoxiconazole results in decreased expression of SLC2A5 mRNA CTD PMID:35436446 ethyl methanesulfonate increases expression ISO SLC2A5 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of SLC2A5 mRNA CTD PMID:23649840 formaldehyde increases expression ISO SLC2A5 (Homo sapiens) 6480464 Formaldehyde results in increased expression of SLC2A5 mRNA CTD PMID:23649840 formaldehyde decreases expression ISO SLC2A5 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of SLC2A5 mRNA CTD PMID:27664576 fructose multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 [Fructose results in increased abundance of Cyclic AMP] which results in increased stability of SLC2A5 mRNA more ... CTD PMID:12820898 fructose increases activity EXP 6480464 Fructose results in increased activity of SLC2A5 protein CTD PMID:10554124 more ... fructose increases expression ISO Slc2a5 (Mus musculus) 6480464 Fructose results in increased expression of SLC2A5 mRNA CTD PMID:12031501 more ... fructose increases transport ISO SLC2A5 (Homo sapiens) 6480464 SLC2A5 protein results in increased transport of Fructose CTD PMID:1634504 more ... fructose increases expression ISO SLC2A5 (Homo sapiens) 6480464 Fructose results in increased expression of SLC2A5 mRNA and Fructose results in increased expression of SLC2A5 protein CTD PMID:12820898 and PMID:8554516 fructose increases uptake EXP 6480464 SLC2A5 protein results in increased uptake of Fructose CTD PMID:11123204 and PMID:11518678 fructose increases transport EXP 6480464 SLC2A5 protein results in increased transport of Fructose CTD PMID:15457374 and PMID:9486174 fructose affects expression EXP 6480464 Fructose affects the expression of SLC2A5 mRNA CTD PMID:15150374 fructose increases expression EXP 6480464 Fructose analog results in increased expression of SLC2A5 mRNA more ... CTD PMID:10222385 more ... fructose increases transport ISO Slc2a5 (Mus musculus) 6480464 SLC2A5 protein results in increased transport of Fructose CTD PMID:12031501 fructose multiple interactions EXP 6480464 1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [Fructose results in increased expression of and results in increased activity of SLC2A5 protein] more ... CTD PMID:11123204 more ... fructose multiple interactions ISO Slc2a5 (Mus musculus) 6480464 lactisole inhibits the reaction [Fructose results in increased expression of SLC2A5 mRNA] CTD PMID:17786952 fructose increases activity ISO Slc2a5 (Mus musculus) 6480464 Fructose results in increased activity of SLC2A5 protein CTD PMID:19907007 fulvestrant multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC2A5 gene CTD PMID:31601247 furan decreases expression ISO Slc2a5 (Mus musculus) 6480464 furan results in decreased expression of SLC2A5 mRNA CTD PMID:24183702 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC2A5 mRNA CTD PMID:33387578 glucose multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 Colforsin promotes the reaction [Glucose results in increased expression of SLC2A5 mRNA] and Glucose promotes the reaction [PAIP2 protein binds to SLC2A5 3' UTR] CTD PMID:12820898 glucose increases expression ISO SLC2A5 (Homo sapiens) 6480464 Glucose results in increased expression of SLC2A5 mRNA and Glucose results in increased expression of SLC2A5 protein CTD PMID:12820898 and PMID:8554516 glucose increases expression EXP 6480464 Glucose results in increased expression of SLC2A5 protein CTD PMID:8048533 glucose increases expression ISO Slc2a5 (Mus musculus) 6480464 Glucose results in increased expression of SLC2A5 mRNA CTD PMID:12937289 glucose increases transport ISO SLC2A5 (Homo sapiens) 6480464 SLC2A5 protein results in increased transport of Glucose CTD PMID:17710649 GW 4064 increases expression ISO Slc2a5 (Mus musculus) 6480464 GW 4064 results in increased expression of SLC2A5 mRNA CTD PMID:26655953 hydroquinone decreases expression ISO SLC2A5 (Homo sapiens) 6480464 hydroquinone results in decreased expression of SLC2A5 mRNA CTD PMID:31256213 Indeno[1,2,3-cd]pyrene decreases expression ISO Slc2a5 (Mus musculus) 6480464 indeno(1 more ... CTD PMID:26377693 indometacin multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SLC2A5 mRNA CTD PMID:28628672 iron atom decreases expression ISO SLC2A5 (Homo sapiens) 6480464 Iron deficiency results in decreased expression of SLC2A5 mRNA CTD PMID:20368581 iron atom decreases expression EXP 6480464 Iron deficiency results in decreased expression of SLC2A5 mRNA CTD PMID:16629162 iron(0) decreases expression EXP 6480464 Iron deficiency results in decreased expression of SLC2A5 mRNA CTD PMID:16629162 iron(0) decreases expression ISO SLC2A5 (Homo sapiens) 6480464 Iron deficiency results in decreased expression of SLC2A5 mRNA CTD PMID:20368581 ketamine increases expression EXP 6480464 Ketamine results in increased expression of SLC2A5 mRNA CTD PMID:20080153 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of SLC2A5 mRNA CTD PMID:22641619 levonorgestrel multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SLC2A5 mRNA CTD PMID:19074003 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Fructose results in increased expression of and results in increased activity of SLC2A5 protein] CTD PMID:15691865 metformin increases expression EXP 6480464 Metformin results in increased expression of SLC2A5 mRNA CTD PMID:31324951 methamphetamine increases expression ISO SLC2A5 (Homo sapiens) 6480464 Methamphetamine results in increased expression of SLC2A5 protein CTD PMID:20110187 methylarsonic acid multiple interactions ISO Slc2a5 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC2A5 mRNA CTD PMID:34876320 mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Fructose results in increased activity of SLC2A5 protein]] and Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Fructose results in increased expression of SLC2A5 mRNA]] CTD PMID:18556366 mirtazapine increases expression ISO SLC2A5 (Homo sapiens) 6480464 mirtazapine results in increased expression of SLC2A5 mRNA CTD PMID:16002093 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Bucladesine results in increased expression of and results in increased stability of SLC2A5 mRNA] CTD PMID:12820898 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of SLC2A5 mRNA CTD PMID:19638242 nickel atom affects expression ISO SLC2A5 (Homo sapiens) 6480464 Nickel affects the expression of SLC2A5 mRNA CTD PMID:14575637 nickel atom increases expression ISO SLC2A5 (Homo sapiens) 6480464 Nickel results in increased expression of SLC2A5 mRNA CTD PMID:25583101 nickel atom multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of SLC2A5 mRNA] CTD PMID:14575637 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of SLC2A5 mRNA CTD PMID:16251485 ozone decreases expression ISO Slc2a5 (Mus musculus) 6480464 Ozone results in decreased expression of SLC2A5 mRNA CTD PMID:31626304 paracetamol affects expression ISO Slc2a5 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC2A5 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC2A5 mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid multiple interactions ISO Slc2a5 (Mus musculus) 6480464 [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of SLC2A5 mRNA CTD PMID:33483757 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of SLC2A5 mRNA CTD PMID:31324951 phenobarbital increases expression ISO Slc2a5 (Mus musculus) 6480464 Phenobarbital results in increased expression of SLC2A5 mRNA CTD PMID:19270015 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of SLC2A5 mRNA CTD PMID:19162173 pioglitazone multiple interactions ISO Slc2a5 (Mus musculus) 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC2A5 mRNA CTD PMID:27935865 pioglitazone decreases expression ISO SLC2A5 (Homo sapiens) 6480464 Pioglitazone results in decreased expression of SLC2A5 mRNA CTD PMID:30031879 pirinixic acid multiple interactions ISO Slc2a5 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC2A5 mRNA and [pirinixic acid co-treated with PPARA] results in decreased expression of SLC2A5 mRNA CTD PMID:19710929 and PMID:20813756 pirinixic acid decreases expression ISO Slc2a5 (Mus musculus) 6480464 pirinixic acid results in decreased expression of SLC2A5 mRNA CTD PMID:20813756 and PMID:23811191 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of SLC2A5 mRNA CTD PMID:19162173 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of SLC2A5 mRNA CTD PMID:19423681 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SLC2A5 mRNA CTD PMID:28374803 silicon dioxide increases expression ISO SLC2A5 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of SLC2A5 mRNA CTD PMID:23806026 sodium arsenate multiple interactions ISO Slc2a5 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC2A5 mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO Slc2a5 (Mus musculus) 6480464 sodium arsenite results in decreased expression of SLC2A5 mRNA CTD PMID:37682722 sodium arsenite multiple interactions ISO Slc2a5 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SLC2A5 mRNA CTD PMID:34876320 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of SLC2A5 mRNA CTD PMID:25993096 sodium fluoride increases expression ISO Slc2a5 (Mus musculus) 6480464 Sodium Fluoride results in increased expression of SLC2A5 protein CTD PMID:28918527 Soman increases expression EXP 6480464 Soman results in increased expression of SLC2A5 mRNA CTD PMID:19281266 sucrose increases expression EXP 6480464 Sucrose results in increased expression of SLC2A5 mRNA CTD PMID:10222385 and PMID:9124564 sulforaphane decreases expression ISO SLC2A5 (Homo sapiens) 6480464 sulforaphane results in decreased expression of SLC2A5 mRNA CTD PMID:31838189 tamibarotene increases expression ISO SLC2A5 (Homo sapiens) 6480464 tamibarotene results in increased expression of SLC2A5 mRNA CTD PMID:15498508 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of SLC2A5 mRNA CTD PMID:19224547 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of SLC2A5 mRNA] CTD PMID:20032058 testosterone undecanoate multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SLC2A5 mRNA CTD PMID:19074003 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC2A5 mRNA and Carbon Tetrachloride results in decreased expression of SLC2A5 protein CTD PMID:17544377 and PMID:19224547 tetrachloromethane decreases expression ISO Slc2a5 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of SLC2A5 mRNA CTD PMID:31919559 tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of SLC2A5 mRNA CTD PMID:19224547 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC2A5 mRNA CTD PMID:23411599 and PMID:34492290 titanium dioxide decreases expression ISO Slc2a5 (Mus musculus) 6480464 titanium dioxide results in decreased expression of SLC2A5 mRNA CTD PMID:23557971 toluene affects expression EXP 6480464 Toluene affects the expression of SLC2A5 mRNA CTD PMID:18653662 triadimefon decreases expression EXP 6480464 triadimefon results in decreased expression of SLC2A5 mRNA CTD PMID:19423681 tributylstannane increases expression ISO Slc2a5 (Mus musculus) 6480464 tributyltin results in increased expression of SLC2A5 mRNA CTD PMID:31939706 trichostatin A multiple interactions ISO SLC2A5 (Homo sapiens) 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of SLC2A5 mRNA] CTD PMID:14575637 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of SLC2A5 mRNA CTD PMID:30589522 triptonide increases expression ISO Slc2a5 (Mus musculus) 6480464 triptonide results in increased expression of SLC2A5 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO SLC2A5 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of SLC2A5 mRNA CTD PMID:29024780 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of SLC2A5 protein CTD PMID:11244250 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of SLC2A5 mRNA CTD PMID:24136188 valproic acid increases methylation ISO SLC2A5 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of SLC2A5 gene CTD PMID:29154799 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of SLC2A5 mRNA CTD PMID:19224547 vancomycin increases expression ISO Slc2a5 (Mus musculus) 6480464 Vancomycin results in increased expression of SLC2A5 mRNA CTD PMID:18930951 wortmannin multiple interactions EXP 6480464 wortmannin inhibits the reaction [Fructose results in increased expression of and results in increased activity of SLC2A5 protein] CTD PMID:15691865 zinc atom increases expression ISO SLC2A5 (Homo sapiens) 6480464 Zinc deficiency results in increased expression of SLC2A5 mRNA CTD PMID:22171008 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of SLC2A5 mRNA CTD PMID:11717422 zinc(0) increases expression ISO SLC2A5 (Homo sapiens) 6480464 Zinc deficiency results in increased expression of SLC2A5 mRNA CTD PMID:22171008 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of SLC2A5 mRNA CTD PMID:11717422
